“The unique fusion of individual innovative technologies will provide a novel diagnostic tool leading to a better understanding of the underlying pathophysiology of rare anaemia.”

Lars Kaestner, Coordinator of CoMMiTMenT

News archive

  • Nov
    CoMMiTMenT beneficiary ORX at BioJapan 2016
    CoMMiTMenT beneficiary ORX was invited to exhibit at the Scandinavian booth at the 18th BioJapan conference in Yokohama, Japan, which took place from 12 to 14 October, 2016. ORX was proud to follow the invitation, which was an excellent opportunity to present their latest developments to an international audience in many face-to-face meetings and also distribute the CoMMiTMenT project flyer to...
  • Oct
    CoMMiTMenT Consortium holds 5th Progress Meeting
    Coordinator Lars Kaestner was pleased to welcome the CoMMiTMenT consortium to the 5th Progress Meeting, which took place on 6th October 2016. This time, the CoMMiTMenT consortium decided to hold their progress meeting via web conference, the platform for which was kindly provided by software partner Arivis AG. This rather unusual way of arranging a progress meeting was chosen in order to allow...
  • May
    CoMMiTMenT Partner OptoRobotix ApS presents research results on light-driven micro-tool equipped with a syringe function in Nature Publishing Group
    OptoRobotix ApS, consortium member in the EC-funded FP7 project CoMMiTMent and H2020 ITN RELEVANCE, and the PPO research group at DTU Fotonik made the top story in the Danish online tech-magazine Ingeniøren with their research results on a light-driven micro-tool equipped with a syringe function. Their corresponding paper, accepted for publication in Light: Science and Application by Nature...
  • Mar
    CoMMiTMenT Coordinator Dr Lars Kaestner gives invited presentation at the German Pharm-Tox Summit
    From 29th February to 3rd March 2016, the ‘German Pharm-Tox Summit’ took place at the Free University in Berlin. This prestigious event brings together basic scientists and clinical pharmacologists every year, thus enabling intensive knowledge transfer. Within the ‘Advanced Courses in Pharmacology’, Dr Lars Kaestner, CoMMiTMenT coordinator of Saarland University, gave an invited presentation on...
  • Dec
    Epigem makes progress on CoMMiTMenT
    Epigem, a high-tech British micro engineering company, has made significant progress on the CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments) project including mimicking functions of the spleen. The project’s clinical partners are now testing devices created by Epigem, which are based on their microfluidics abilities. These work by...
  • Nov
    CoMMiTMenT Consortium gathers for 4th Progress Meeting in London
    Almost exactly 2 years after the project’s kick-off, CoMMiTMenT coordinator Lars Kaestner of Saarland University welcomed the CoMMiTMenT consortium at the Royal Society of Medicine in London, where the Marcus Beck Library provided a dignified setting for the 4th Progress Meeting. As dense fog cut off London airports from traffic, some participants’ flights were cancelled; however, the technical...
  • Oct
    The Campaign for a European Year for Rare Diseases 2019
    Every year, the EU chooses a specific subject to encourage debate and dialogue within and between European countries. The aim of the European Year is to raise awareness of a certain topic. A European Year can also send a strong political signal to gain a commitment from EU institutions and Member State governments that the subject will be taken into consideration in future policymaking. 2019...